Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... given the somewhat tongue-twisting brand name of Ohtuvayre – is the first ...
Hosted on MSN9mon
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's OzempicThe Federal Trade Commission said it is challenging hundreds of alleged "junk" patents held by pharmaceutical companies for 20 brand-name ... or COPD. Most top-selling medications are protected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback